PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'University Cardiology, A.O.U. Città della Salute e della Scienza di Torino, Turin.\', \'Dipartimento Scienze Biomediche e Cliniche Luigi Sacco, ASST Fatebenefratelli-Sacco, Università degli Studi di Milano, Milan, Italy.\', \'First Cardiology Department, Hippokration General Hospital, National and Kapodistrian University of Athens, Greece.\', \'Internal Medicine Department, ASST Valcamonica, Brescia, Italy.\', \'Center for the Diagnosis and Treatment for Pericardial Diseases, Cleveland Clinic, USA.\', \'College of Law and Business, Ramat Gan, Israel, Sackler Faculty of Medicine, Tel Aviv University, Mayanei Hayeshua Medical Center, Bnei Brak, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.2459/JCM.0000000000001059
?:hasPublicationType
?:journal
  • Journal of cardiovascular medicine (Hagerstown, Md.)
is ?:pmid of
?:pmid
?:pmid
  • 32658005
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Anti-inflammatory therapies for pericardial diseases in the COVID-19 pandemic: safety and potentiality.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all